(Q45309152)

12 December 2017

title

A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1. (English)

1 reference

12 December 2017

4

C Haferlach

1 reference

12 December 2017

L Solari

1

1 reference

12 December 2017

T Bauer

2

1 reference

12 December 2017

F Dicker

3

1 reference

12 December 2017

M Grießhammer

5

1 reference

12 December 2017

S Schnittger

6

1 reference

12 December 2017

H Becker

7

1 reference

12 December 2017

M Lübbert

8

1 reference

12 December 2017

publication date

21 February 2013

1 reference

12 December 2017

1 reference

12 December 2017

volume

27

1 reference

12 December 2017

issue

6

1 reference

12 December 2017

page(s)

1397-1400

1 reference

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

12 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Allo-SCT in a rare t(8;21) evolution of CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

8/21 translocation, loss of the Y chromosome and Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

inferred from DOI database lookup

7 January 2021

based on heuristic

Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.53

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2013.53

1 reference

Dimensions Publication ID

12 December 2017

1019242425

0 references

1 reference